Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas

The trial will use neoadjuvant hypofractionated radiotherapy followed by surgical resection in the treatment for soft tissue sarcoma. It will allow patients to be treated over a shorter course (5 or 15 days of radiation) compared to the traditional 5 week regimen. It is proposed that this will be possible without increasing the risk of wound complication or local recurrence compared with a traditional 5 week course of pre-operative radiation.
Sarcoma
Phase II
Adults
Not Available
Not Available
Shinohara, Eric
Local
Vanderbilt University
01-11-2021
Treatment
VICCSAR2062
NCT04506008

Eligibility

18 Years and older
ALL
false
Inclusion Criteria:

Histologic diagnosis of a soft tissue sarcoma of extremity, pelvis, chest wall or trunk/abdominal wall (non-retroperitoneal location)

Histologic diagnosis of a soft tissue sarcoma of extremity, pelvis, chest wall or trunk/abdominal wall (non-retroperitoneal location)

ECOG performance status 0-2

ECOG performance status 0-2

Patient must be deemed able to comply with radiation treatment and surgery

Patient must be deemed able to comply with radiation treatment and surgery



Exclusion Criteria:

History of prior radiation to the same area to be irradiated

History of prior radiation to the same area to be irradiated

Pregnancy

Pregnancy

Active collagen vascular disease or patients genetically predisposed to increased radiation related side effects

Active collagen vascular disease or patients genetically predisposed to increased radiation related side effects

To learn more about any of our clinical
trials, call 615-936-8422.